(DBX1) Xtrackers - MSCI Emerging - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0292107645 • Global Emerging Markets Equity

DBX1: Emerging Markets, Equities, Stocks

The Xtrackers - MSCI Emerging Markets Swap UCITS ETF (Ticker: DBX1) is a German-domiciled exchange-traded fund designed to provide exposure to emerging markets equities. Listed on XETRA, it is structured as a swap-based ETF, utilizing derivatives to replicate the performance of its target index, the Morningstar EM TME NR USD. This index tracks the performance of equities in emerging markets, offering a broad representation of companies across various regions and sectors.

With assets under management (AUM) of 732.57 million EUR, this ETF is a sizable fund, indicating significant investor interest in its emerging markets exposure. The funds swap-based structure allows it to efficiently track the underlying index while managing tracking error. As a UCITS-compliant ETF, it adheres to European regulatory standards, ensuring transparency and investor protection. Additional information on the fund can be accessed through the issuers website at http://www.dws.lu.

Looking ahead, the future outlook for the Xtrackers - MSCI Emerging Markets Swap UCITS ETF will likely hinge on the broader trends in emerging markets. As these economies continue to grow, albeit with inherent volatility, the fund stands to benefit from increasing investor appetite for higher returns in less developed regions. However, factors such as geopolitical risks, currency fluctuations, and economic policy changes could impact performance. The ETFs ability to maintain its tracking efficiency and control costs will remain critical in maintaining its appeal to investors seeking diversified exposure to emerging markets.

Additional Sources for DBX1 ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

DBX1 ETF Overview

Market Cap in USD 794m
Category Global Emerging Markets Equity
TER 0.49%
IPO / Inception 2007-06-22

DBX1 ETF Ratings

Growth 5y 42.2%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -13.7
Analysts -
Fair Price Momentum 45.54 EUR
Fair Price DCF -

DBX1 Dividends

No Dividends Paid

DBX1 Growth Ratios

Growth Correlation 3m 23.9%
Growth Correlation 12m 80.5%
Growth Correlation 5y 23.1%
CAGR 5y 8.82%
CAGR/Max DD 5y 0.33
Sharpe Ratio 12m 0.92
Alpha 2.09
Beta 0.65
Volatility 20.10%
Current Volume 8.5k
Average Volume 20d 5.6k
What is the price of DBX1 stocks?
As of March 13, 2025, the stock is trading at EUR 49.00 with a total of 8,497 shares traded.
Over the past week, the price has changed by -1.41%, over one month by -4.36%, over three months by -2.80% and over the past year by +8.43%.
Is Xtrackers - MSCI Emerging a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Xtrackers - MSCI Emerging (XETRA:DBX1) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 42.19 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBX1 as of March 2025 is 45.54. This means that DBX1 is currently overvalued and has a potential downside of -7.06%.
Is DBX1 a buy, sell or hold?
Xtrackers - MSCI Emerging has no consensus analysts rating.
What are the forecast for DBX1 stock price target?
According to ValueRays Forecast Model, DBX1 Xtrackers - MSCI Emerging will be worth about 50.5 in March 2026. The stock is currently trading at 49.00. This means that the stock has a potential upside of +3.06%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 50.5 3.1%